USPTO serial 79292615
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,300
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina Campagna
Pina Campagna Carter, DeLuca and Farrell LLP576 Broad Hollow Rd.Melville, NY 11747UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and biochemical products in the nature of preparations for scientific use and for research, other than for medical or veterinary use; chemical and biochemical products in the nature of preparations for scientific use and for research in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-viral particles, other than for medical or veterinary use; chemical preparations, agents and reagents for scientific use and for scientific research for genetic diagnosis; chemical and biochemical test kits for scientific laboratory use and for research use containing preparations, agents and reagents, for life science research, virus, protein, antibody production and in vivo injection; chemical and biochemical test kits for scientific laboratory use and for research use containing preparations, agents and reagents in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-viral particles | ACTIVE | — |
| 005 | Chemicals and biochemical for medical and clinical use, namely, chemical and biochemical preparations for genetic diseases; chemicals and biochemical for medical and clinical use in the field of genetics, namely, chemical and biochemical preparations for transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-virus particles for genetic diseases; chemical preparations for medical use for research and for genetic diagnostics, namely, for genetic diseases; diagnostic agents for medical use for research and for genetic diagnostics; reagents for medical use for research and for genetic diagnostics; chemical and biochemical diagnostic reagent test kits for medical and clinical use comprised of medical diagnostic preparations, agents and reagents for use in disease testing; diagnostic assay kits and chemical and biochemical diagnostic test kits, all for medical and clinical use in the field of genetics, comprised of preparations, agents and reagents for transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-virus particles, for use in disease testing; pharmaceutical products for the treatment of genetic diseases; medicines for the treatment of genetic diseases; medical and veterinary diagnostic preparations; sanitary products for medical purposes, namely, sanitary preparations for medical use | ACTIVE | — |
| 035 | Retail and wholesale store services, including online, of transfection agents, products, agents and reagents for scientific and clinical research, in particular in the field of genetics | ACTIVE | — |
| 042 | Chemical and biochemical analyses; genetic analyses for scientific research purposes; structural and functional analysis of genomes; analyses in the field of molecular biology; scientific analyses and research in the field of transfection; software design, computer software design in the field of scientific research and genetic analyses; consulting in relation to research and development of transfections agents and agents, reagents and chemicals and biochemical used in the field of genetics; development of pharmaceutical products; scientific development of transfection agents; development of new products in the field of gene therapy; computer-aided scientific testing of DNA samples for diagnostic purposes; laboratory research in the field of genetics; conducting clinical trials for others for pharmaceutical and genetic products; scientific research in the field of medicines; scientific research in the field of genetics and genetic engineering; scientific research for medical purposes in the field of genetics and genetic engineering; services of a genetic research laboratory, namely, genetic testing for scientific research purposes and development of gene therapies for medical purposes; research and development of new products for third parties; scientific testing services in the field of genetics | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 13, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 1, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 11, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 30, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 31, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 26, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 9, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 9, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 13, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 13, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 27, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 27, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 25, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 7, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 7, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 7, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 24, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 8, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 8, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 8, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 11, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 11, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 10, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 2, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 1, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 1, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 1, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 28, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 28, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 27, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |